BlackRock Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
BIT
BFA
BlackRock Investment Management's EW Position: Q4 2016 in Review
BlackRock Investment Management reduced its Edwards Lifesciences (EW) stake by 3.6% in Q4 2016, selling an estimated $1.72M and leaving 1,438,347 shares worth $44.9M. The position accounts for 0.05% of the portfolio, ranked #337.
BlackRock Investment Management first reported a position in EW in Q2 2013 and has held it in 15 quarters since. The position peaked at $59.9M in Q3 2016. 686 funds tracked by Wall St. Rank hold EW as of Q4 2016.
- BlackRock Investment Management held 1,438,347 shares of Edwards Lifesciences worth $44.9M as of Q4 2016.
- BlackRock Investment Management sold 53,217 Edwards Lifesciences shares in Q4 2016, an estimated $1.72M.
- Edwards Lifesciences made up 0.05% of BlackRock Investment Management's portfolio in Q4 2016, its #337 holding.
- BlackRock Investment Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 15 quarters since.
- BlackRock Investment Management's Edwards Lifesciences position peaked at $59.9M in Q3 2016.
- 686 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2016.
Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.